Daclatasvir, Sofosbuvir, and Ribavirin for Hepatitis C Virus Genotype 3 and Advanced Liver Disease: A Randomized Phase III Study (ALLY-3+) - Leroy, V; Angus, P; Bronowicki, J P (Hepatology, 2016)
et al.